Back to Search
BENJAMIN LEDER, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1982783924IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
152510(MA)
Education
HARVARD MEDICAL SCHOOL
Class of 1994
Clinical Trials (4)
4
Linked Trials
1
Recruiting
2
With Results
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590ACTIVE_NOT_RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
NCT04026256COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
NCT02176382COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Combined Anabolic Therapy
NCT06558188RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
PMID 32790196·J Bone Miner Res·2021
2-rct
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT.
PMID 31674641·J Clin Endocrinol Metab·2020
2-rct
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.
PMID 31447409·Lancet Diabetes Endocrinol·2019
2-rct
Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis.
PMID 19435827·J Clin Endocrinol Metab·2009
8-other
Gonadal steroids and bone metabolism in men.
PMID 17940446·Curr Opin Endocrinol Diabetes Obes·2007
6-review
Is parathyroid hormone (1-84) a safe and effective treatment for postmenopausal osteoporosis?
PMID 17768406·Nat Clin Pract Endocrinol Metab·2007
8-other
Racial and ethnic differences in bone turnover markers in men.
PMID 17579203·J Clin Endocrinol Metab·2007
4-observational
Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
PMID 15856361·Osteoporos Int·2005
2-rct
Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
PMID 15001605·J Clin Endocrinol Metab·2004
3-trial
Differential effects of androgens and estrogens on bone turnover in normal men.
PMID 12519853·J Clin Endocrinol Metab·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15 PARKMAN STREET WAC 730S, ENDOCRINE ASSOCIATES
BOSTON, MA 02114 - Phone
- (617) 726-8720
Quick Facts
- NPI
- 1982783924
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 32
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile